Hurricane Aftermath: MDS Looks To Recover, Pharma Donations Continue
Executive Summary
MDS Pharma is holding discussions with clients concerning the relocation of research originally scheduled to take place in its New Orleans, La. facility, the contract research organization said
You may also be interested in...
Crawford Live: Three-City FDA Tour To Focus On Drug Safety, DTC
Drug safety and DTC advertising will be key topics of discussion during three upcoming FDA public meetings featuring FDA Commissioner Lester Crawford and other top agency officials
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials